Radix astragali postpones organ damage in a rat model of metabolic syndrome through the renin angiotensin system

J. YU,P. CHANG,L. ZHEN,X. GUO,L. YANG,J. LI,P. YAN,X. LI,F. BAI,F. DING

DOI: https://doi.org/10.1016/j.ijcard.2009.09.384

IF: 4.039

2009-01-01

International Journal of Cardiology

Abstract:Objective This study was designed to evaluate the effect of radix astragali, a kind of Chinese herb medicine on gene expressions of angiotensin-converting enzyme 2 (ACE2) and angiotensin-converting enzyme (ACE) on the heart, kidney and aorta as well as their tissue levels of angiotensin II (Ang II) in a rat model of metabolic syndrome (MS). Methods Sixty adult male Wistar rats were grouped randomly as normal control, fructose-induced MS group, MS +valsartan group, MS+radix astragali 1.5 g/kg d group, MS+radix astragali 3.0 g/kg d group and MS+radix astragali 6.0 g/kg d group. The metabolic indexes including SBP, TG, HDL-C, free fatty acids (FFA), Lee's index, plasma insulin and insulin sensitive index (ISI) were achieved to confirm the model's establishing. Real time PCR and Western blot were used to judge differences of ACE and ACE2. Ang II was measured by radioimmunoassay. Results After 6 weeks of treatment, the expression of ACE mRNA was up regulated while ACE2 mRNA was down regulated in these organs of the MS group (all P<0.01). Both radix astragali and valsartan improved metabolic indexes (P<0.05 or 0.01). Ang II of the heart, kidney and aorta was higher in the valsartan group compared with that of the MS group (P<0.01) but lower dosage dependently in the radix astragali group (P<0.05). Radix astragali dosage dependently lowered the expression of mRNA and protein content of ACE and had an equal effect with valsartan (P<0.05). Radix astragali (dosage dependently) and valsartan increased the mRNA expression and protein content of ACE2 (P<0.05 or <0.01). Conclusion Radix astragali possesses a similar ability with valsartan to recuperate the imbalance of ACE and ACE2, improve metabolic indexes and therefore protect organs from the damage of MS. Objective This study was designed to evaluate the effect of radix astragali, a kind of Chinese herb medicine on gene expressions of angiotensin-converting enzyme 2 (ACE2) and angiotensin-converting enzyme (ACE) on the heart, kidney and aorta as well as their tissue levels of angiotensin II (Ang II) in a rat model of metabolic syndrome (MS). Methods Sixty adult male Wistar rats were grouped randomly as normal control, fructose-induced MS group, MS +valsartan group, MS+radix astragali 1.5 g/kg d group, MS+radix astragali 3.0 g/kg d group and MS+radix astragali 6.0 g/kg d group. The metabolic indexes including SBP, TG, HDL-C, free fatty acids (FFA), Lee's index, plasma insulin and insulin sensitive index (ISI) were achieved to confirm the model's establishing. Real time PCR and Western blot were used to judge differences of ACE and ACE2. Ang II was measured by radioimmunoassay. Results After 6 weeks of treatment, the expression of ACE mRNA was up regulated while ACE2 mRNA was down regulated in these organs of the MS group (all P<0.01). Both radix astragali and valsartan improved metabolic indexes (P<0.05 or 0.01). Ang II of the heart, kidney and aorta was higher in the valsartan group compared with that of the MS group (P<0.01) but lower dosage dependently in the radix astragali group (P<0.05). Radix astragali dosage dependently lowered the expression of mRNA and protein content of ACE and had an equal effect with valsartan (P<0.05). Radix astragali (dosage dependently) and valsartan increased the mRNA expression and protein content of ACE2 (P<0.05 or <0.01). Conclusion Radix astragali possesses a similar ability with valsartan to recuperate the imbalance of ACE and ACE2, improve metabolic indexes and therefore protect organs from the damage of MS.